399441 生物医药
已收盘 07-03 15:00:00
资讯
新帖
简况
景泽生物医药（合肥）股份有限公司递表港交所
第一财经 · 07-03 22:56
景泽生物医药（合肥）股份有限公司递表港交所
7月3日甘李药业涨6.53%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 07-03 16:28
7月3日甘李药业涨6.53%，招商国证生物医药指数(LOF)C基金重仓该股
东湖高新：该联合创新中心由上海市肿瘤研究所、佳维斯（武汉）生物医药有限公司、东湖高新集团联合共建，不涉及合资
证券之星 · 07-03 16:06
东湖高新：该联合创新中心由上海市肿瘤研究所、佳维斯（武汉）生物医药有限公司、东湖高新集团联合共建，不涉及合资
港股异动 | 派格生物医药-B(02565)涨超5% 维培那肽注射液通过26年国家医保目录调整初步形式审查
智通财经 · 07-02
港股异动 | 派格生物医药-B(02565)涨超5% 维培那肽注射液通过26年国家医保目录调整初步形式审查
康华生物最新公告：拟出资3.6亿元参与设立生物医药产业投资基金
证券之星 · 07-01
康华生物最新公告：拟出资3.6亿元参与设立生物医药产业投资基金
6月29日甘李药业涨7.07%，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 06-29
6月29日甘李药业涨7.07%，招商国证生物医药指数(LOF)C基金重仓该股
美股生物医药股盘中走强，Moderna涨超11%，强生涨超3%
老虎资讯综合 · 06-26
美股生物医药股盘中走强，Moderna涨超11%，强生涨超3%
6月26日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 06-26
6月26日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
国投资本：支持新一代信息技术、生物医药等行业
证券之星 · 06-26
国投资本：支持新一代信息技术、生物医药等行业
派格生物医药-B公布完成H股全流通
新浪港股 · 06-26
派格生物医药-B公布完成H股全流通
保龄宝：公司乳果糖原料药属于生物医药上游原料赛道
证券之星 · 06-25
保龄宝：公司乳果糖原料药属于生物医药上游原料赛道
生物医药企业Kardigan美股上市：市值19亿美元 路演PPT曝光
雷递 · 06-21
生物医药企业Kardigan美股上市：市值19亿美元 路演PPT曝光
生物医药企业Kardigan美股上市：市值19亿美元 路演PPT曝光
雷递网 · 06-20
生物医药企业Kardigan美股上市：市值19亿美元 路演PPT曝光
东瑞制药：拟向上海建信东瑞生物医药创业投资基金出资1亿元人民币
南方财经网 · 06-18
东瑞制药：拟向上海建信东瑞生物医药创业投资基金出资1亿元人民币
6月17日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 06-17
6月17日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
港股异动 | 君实生物(01877)涨超5% 近日拟入股上海致域生物医药 布局ADC与多特异抗体研发
智通财经 · 06-12
港股异动 | 君实生物(01877)涨超5% 近日拟入股上海致域生物医药 布局ADC与多特异抗体研发
科伦博泰生物(06990)收到宜联生物医药根据已达成和解支付的相关款项
智通财经 · 06-12
科伦博泰生物(06990)收到宜联生物医药根据已达成和解支付的相关款项
生物医药企业迈科康科创板IPO已问询 三年累计亏损11.41亿元
智通财经 · 06-11
生物医药企业迈科康科创板IPO已问询 三年累计亏损11.41亿元
新莱应材：产品目前主要应用于泛半导体、生物医药和食品安全等业务领域
证券之星 · 06-09
新莱应材：产品目前主要应用于泛半导体、生物医药和食品安全等业务领域
中国宝安：公司控股及参股的企业涵盖高新技术、生物医药、房地产等产业
证券日报网 · 06-08
中国宝安：公司控股及参股的企业涵盖高新技术、生物医药、房地产等产业
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"399441","market":"SZ","secType":"STK","nameCN":"生物医药","latestPrice":2087.72,"timestamp":1783062198000,"preClose":2034.15,"halted":0,"volume":664374055,"delay":0,"changeRate":0.0263,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":53.57,"latestTime":"07-03 15:00:00","open":2052.91,"high":2091.45,"low":2022.08,"amount":28849000000,"amplitude":0.0341,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":5,"adr":0,"adjPreClose":2034.15,"symbolType":"index","openAndCloseTimeList":[[1783042200000,1783049400000],[1783054800000,1783062000000]],"highLimit":0,"lowLimit":0,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/399441","defaultTab":"news","newsList":[{"id":"2648664627","title":"景泽生物医药（合肥）股份有限公司递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2648664627","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648664627?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:56","pubTimestamp":1783090560,"startTime":"0","endTime":"0","summary":"据港交所文件，景泽生物医药（合肥）股份有限公司向港交所提交上市申请书，联席保荐人为中金公司、国元国际。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-07-03/doc-inifpyys3567142.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-07-03/doc-inifpyys3567142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HEXmain","BK4585","399441","161726","XBI","BK4588","IPOS","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648765415","title":"7月3日甘李药业涨6.53%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648765415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648765415?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:28","pubTimestamp":1783067331,"startTime":"0","endTime":"0","summary":"证券之星消息，7月3日甘李药业涨6.53%，收盘报60.99元，换手率3.3%，成交量18.5万手，成交额11.13亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共42家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.1亿元，最新净值0.3762，较上一交易日下跌1.1%，近一年下跌1.78%。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300029610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","BK0239","399441","603087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648654865","title":"东湖高新：该联合创新中心由上海市肿瘤研究所、佳维斯（武汉）生物医药有限公司、东湖高新集团联合共建，不涉及合资","url":"https://stock-news.laohu8.com/highlight/detail?id=2648654865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648654865?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:06","pubTimestamp":1783065981,"startTime":"0","endTime":"0","summary":"投资者提问：公司微信公众号1月27日发布“1月23日，由上海市肿瘤研究所、佳维斯（武汉）生物医药有限公司、湖北联投东湖高新集团联合共建的高端生物医学成像与肿瘤系统研究联合创新中心在武汉精准医疗产业基地正式揭牌。”该联合创新中心由上海市肿瘤研究所、佳维斯（武汉）生物医药有限公司、东湖高新集团联合共建，不涉及合资。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300027851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","BK0086","399441","BK0277","BK0102","600133","BK0075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648571593","title":"港股异动 | 派格生物医药-B(02565)涨超5% 维培那肽注射液通过26年国家医保目录调整初步形式审查","url":"https://stock-news.laohu8.com/highlight/detail?id=2648571593","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648571593?lang=zh_cn&edition=full","pubTime":"2026-07-02 13:39","pubTimestamp":1782970769,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，派格生物医药-B涨超5%，截至发稿，涨4.13%，报5.55港元，成交额3902.16万港元。消息面上，近日，派格生物医药-B发布公告，本集团核心产品维培那肽注射液已被列入国家医疗保障局公布的《2026年国家基本医疗保险、工伤保险和生育保险药品目录及商保创新药目录调整通过初步形式审查的申报药品名单》，位列“目录外西药和中成药-基本目录”第242项，药品类别为西药，通过申报条件为“目录外条件1”，并标注为独家品种。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4581","399441","BK1161","XBI","BK4588","VXUS","BK4585","02565","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648517183","title":"康华生物最新公告：拟出资3.6亿元参与设立生物医药产业投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2648517183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648517183?lang=zh_cn&edition=full","pubTime":"2026-07-01 19:09","pubTimestamp":1782904176,"startTime":"0","endTime":"0","summary":"康华生物(300841.SZ)公告称，公司拟与四川创新发展投资管理有限公司、四川省先进制造投资引导基金合伙企业(有限合伙)、四川产业振兴基金投资集团有限公司或其指定主体、上海上实生物医药管理咨询有限公司共同出资设立四川振兴生物医药产业投资基金合伙企业(有限合伙)。该基金首期认缴出资总额为12亿元，公司作为有限合伙人拟以自有资金认缴出资3.6亿元，占出资总额的30%。本次交易构成关联交易，尚需获得公司股东会批准。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100036918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","300841","399441","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647432497","title":"6月29日甘李药业涨7.07%，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647432497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647432497?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:32","pubTimestamp":1782721934,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日甘李药业涨7.07%，收盘报57.57元，换手率2.45%，成交量13.73万手，成交额7.75亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共42家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.1亿元，最新净值0.3461，较上一交易日下跌2.42%，近一年下跌7.34%。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","399441","603087","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116783699","title":"美股生物医药股盘中走强，Moderna涨超11%，强生涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116783699","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116783699?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:14","pubTimestamp":1782483252,"startTime":"0","endTime":"0","summary":"6月26日，美股生物医药股盘中走强，$Moderna(MRNA)$涨超11%，$强生(JNJ)$涨超3%，$辉瑞(PFE)$、$施贵宝(BMY)$、$默沙东(MRK)$、$诺瓦瓦克斯医药(NVAX)$涨超2%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B42XCP33.USD","IE000SO60NU8.SGD","LU1732800096.USD","IE00BLSP4452.SGD","LU1629891620.HKD","LU1244550221.USD","LU1551013425.SGD","LU2430703251.USD","LU0210528500.USD","LU1935042991.SGD","LU2756315318.SGD","LU2471134523.USD","LU1506573853.SGD","IE000WAW04H5.SGD","LU0640476718.USD","LU2023250330.USD","IE00B1BXHZ80.USD","LU0912757837.SGD","LU0345770993.USD","LU1059921491.USD","LU1221951046.USD","LU1228905037.USD","IE0002270589.USD","IE0034235303.USD","LU0994945656.USD","LU0466842654.USD","BK4568","LU2417539215.USD","IE00B3T34201.USD","IE00BBT3K403.USD","BK4504","LU2750360641.GBP","SG9999001176.SGD","IE0001KFT4U8.USD","LU1043141396.HKD","LU0098860793.USD","IE00BZ1G4Q59.USD","LU0889566641.SGD","IE00BJJMRZ35.SGD","LU1585245621.USD","LU1983299246.USD","LU2347655156.SGD","LU1066053197.SGD","IE00B19Z3581.USD","LU0820562030.AUD","IE000M9KFDE8.USD","IE00B7SZLL34.SGD","SGXZ57979304.SGD","LU0795875086.SGD","LU1066051811.HKD","IE00BSNM7G36.USD","LU2129689605.HKD","IE00B2B36J28.USD","LU0070217475.USD","SG9999001440.SGD","LU0426412945.USD","LU1496350502.SGD","BK4581","LU2430703178.SGD","IE00BFTCPJ56.SGD","LU2133065610.SGD","LU2213496289.HKD","LU2236285917.USD","BK4534","LU1061106388.HKD","161726","LU0787776722.HKD","LU1032466523.USD","LU0058720904.USD","LU2456880835.USD","IE0000B7K699.USD","BK4532","IE000MB6IJN5.SGD","LU1057294990.SGD","IE00BN8TJ469.HKD","LU0795875169.SGD","LU1732799900.SGD","IE00BDGV0183.EUR","LU1066051498.USD","IE000BZT7R73.USD","LU1244550577.SGD","LU0432979614.USD","LU0345769128.USD","LU0345769631.USD","LU0683600562.USD","IE00BVYPNW00.USD","LU1778281490.HKD","JNJ","IE00BGHQF631.EUR","SG9999013999.USD","LU0985320562.USD","LU1280957306.USD","LU0114720955.EUR","LU1228905540.USD","LU2430703095.HKD","SG9999002224.SGD","IE00BLSP4239.USD","LU0053666078.USD","IE00B3PB1722.GBP","LU0289739699.SGD","LU2750360997.AUD","LU1929549753.HKD","IE00BKVL7J92.USD","LU1145028129.USD","IE00BVYPNV92.GBP","LU1023059063.AUD","LU1674673428.USD","LU2112291526.USD","LU2471134952.CNY","LU0234572021.USD","LU1066051225.USD","LU0426417589.USD","LU1718418525.SGD","BK4559","LU1196500208.SGD","LU1914381329.SGD","LU2756315664.SGD","LU2129689431.USD","BK4550","LU0320765646.SGD","LU1043141123.HKD","LU1894683348.USD","LU1674673691.USD","LU2471134796.USD","399441","BK4007","LU1551013342.USD","BK4533","LU0203345920.USD","BK4585","SG9999002232.USD","LU0882574055.USD","IE00BJT1NW94.SGD","LU2896262040.SGD","BK4592","IE000F7OJYX1.SGD","LU1894683264.USD","LU0820561818.USD","LU2129689514.USD","LU2403377893.USD","IE00BFXG1179.USD","LU0820561909.HKD","LU0203347892.USD","LU0122379950.USD","LU2602419157.SGD","LU2468319806.SGD","LU1244550494.USD","LU2089984988.USD","LU2471134879.HKD","LU0943347566.SGD","LU0545562505.USD","LU1162221912.USD","LU0792757196.USD","LU1267930813.SGD","LU1074936037.SGD","LU0234570918.USD","LU1261432733.SGD","IE00B4R5TH58.HKD","XBI","LU0689626769.HKD","IE0002141913.USD","LU0345770308.USD","LU0964807845.USD","IE0009355771.USD","LU2505996509.AUD","SG9999001176.USD","LU1032955483.USD","LU2505996681.GBP","LU0124676726.USD","LU0689472784.USD","LU2487616109.SGD","LU0210536198.USD","IE00B19Z3B42.SGD","LU1430594728.SGD","LU2592432038.USD","BK4588","LU1221951129.SGD","LU1121112475.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646358312","title":"6月26日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646358312","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646358312?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:50","pubTimestamp":1782463807,"startTime":"0","endTime":"0","summary":"根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.1亿元，最新净值0.3547，较上一交易日上涨0.91%，近一年下跌6.58%。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600030557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002252","BK0188","BK0239","BK0046","399441","BK0196","BK0028","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646330814","title":"国投资本：支持新一代信息技术、生物医药等行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2646330814","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646330814?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:24","pubTimestamp":1782462266,"startTime":"0","endTime":"0","summary":"国投泰康信托公开报道：股权投资了高端制造、半导体与集成电路、新能源、新材料和生物医药等领域；能不能在合规的情况下详细介绍下投资成果的详细情况？国投泰康信托是较早按照市场化、专业化理念打造股权投资业务板块的信托机构之一，近年来先后通过多种形式支持新一代信息技术、生物医药等行业发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600029747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0028","BK0010","BK0012","159939","600061","399441","161726","BK0020","BK0276","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646398763","title":"派格生物医药-B公布完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2646398763","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646398763?lang=zh_cn&edition=full","pubTime":"2026-06-26 13:39","pubTimestamp":1782452340,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 派格生物医药-B（02565）发布公告，1.02亿股非上市股份转换为H股已于2026年6月25日完成，而转换H股已于2026年6月26日上午九时正起在联交所开始上市。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-06-26/doc-inietfxy2012835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161726","BK4581","BK4585","XBI","399441","02565","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646827815","title":"保龄宝：公司乳果糖原料药属于生物医药上游原料赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2646827815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646827815?lang=zh_cn&edition=full","pubTime":"2026-06-25 15:06","pubTimestamp":1782371179,"startTime":"0","endTime":"0","summary":"证券之星消息，保龄宝(002286)06月25日在投资者关系平台上答复投资者关心的问题。投资者提问：你公司的乳果糖原料药是通过什么技术制作的，大方向上算不算生物医药。另戴斯聪作为欧邦琪的国内业务负责人，有没有可能借助自身的资源，带着保龄宝拓展美妆等新的市场。保龄宝回复：尊敬的投资者您好，公司乳果糖原料药采用化工工艺生产，同时公司储备了生物发酵工艺，该药用原料药属于生物医药上游原料赛道。公司作为功能与健康解决方案服务商，美妆市场是公司产品下游应用的重要领域。谢谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500022013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","BK0028","399441","BK0039","BK0070","161726","BK0238","002286"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645501683","title":"生物医药企业Kardigan美股上市：市值19亿美元 路演PPT曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2645501683","media":"雷递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645501683?lang=zh_cn&edition=full","pubTime":"2026-06-21 19:32","pubTimestamp":1782041520,"startTime":"0","endTime":"0","summary":"雷递网 雷建平 6月21日美国心血管生物医药企业Kardigan日前在美国纳斯达克上市，发行价为16美元。Kardigan发行价为16美元，发行2500万股，募资总额为4亿美元。截至今日收盘，Kardigan股价为22美元，较发行价上涨37.5%；以今日收盘价计算，公司市值为19.29亿美元。Kardigan在2024年、2025您净亏损分别为8866万美元、1.92亿美元；2026年第一季度净亏损为5607万美元。截至2026年3月31日，Kardigan一共有2.87亿美元的现金、现金等价物、短期投资。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MjM5MzQ5NjIyMQ==&mid=2661676126&idx=4&sn=ab0eba02a58fe4753c1798ad22e1a3fe&chksm=bdc779ac8ab0f0ba5d56364608a29addc59215bb31685eb03009e67a05767b609088d18560ef#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["399441","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644206089","title":"生物医药企业Kardigan美股上市：市值19亿美元 路演PPT曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2644206089","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644206089?lang=zh_cn&edition=full","pubTime":"2026-06-20 18:30","pubTimestamp":1781951405,"startTime":"0","endTime":"0","summary":"美国心血管生物医药企业Kardigan（股票代码：“KARD”）日前在美国纳斯达克上市，发行价为16美元。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260620/6391757686513187695524647.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260620/6391757686513187695524647.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n34089/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["XBI","IPOS","PPT","BK4585","BK4581","KARD","161726","BK4588","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644208403","title":"东瑞制药：拟向上海建信东瑞生物医药创业投资基金出资1亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2644208403","media":"南方财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644208403?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:44","pubTimestamp":1781793840,"startTime":"0","endTime":"0","summary":"南财智讯6月18日电，东瑞制药（02348.HK）发布须予披露交易公告，于2026年6月18日，公司全资附属公司苏州东瑞作为有限合伙人，与中建信（有限合伙人）及上海建信（普通合伙人）订立有限合伙协议，拟共同设立上海建信东瑞生物医药创业投资基金合伙企业（有限合伙），苏州东瑞承诺出资最高达人民币100000000元，占合伙企业拟定资本的50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606183776507447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4581","XBI","BK1191","BK4588","161726","BK4585","399441","02348"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644711777","title":"6月17日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644711777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644711777?lang=zh_cn&edition=full","pubTime":"2026-06-17 16:37","pubTimestamp":1781685443,"startTime":"0","endTime":"0","summary":"根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.1亿元，最新净值0.3342，较上一交易日下跌1.24%，近一年下跌13.7%。招商国证生物医药指数C的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700028022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","399441","161726","BK0028","BK0188","BK0046","BK0196","002252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642250194","title":"港股异动 | 君实生物(01877)涨超5% 近日拟入股上海致域生物医药 布局ADC与多特异抗体研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2642250194","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642250194?lang=zh_cn&edition=full","pubTime":"2026-06-12 15:07","pubTimestamp":1781248026,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，君实生物涨超5%，截至发稿，涨4.67%，报17.26港元，成交额6560.03万港元。消息面上，近日，君实生物发布公告，公司拟与苏州众合、君实工程、苏州君盟、合资公司上海致域生物医药有限公司及姚盛博士订立合资协议，据此，转让方有条件同意向合资公司授予许可知识产权的一项许可，用于许可产品的研究、开发、制造、使用及商业化；向合资公司转让有形资产；及向合资公司转让IP权益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","BK1515","BK4585","XBI","BK4581","BK1161","399441","BK4588","01877","VXUS","BK1583","161726","BK4080","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642307622","title":"科伦博泰生物(06990)收到宜联生物医药根据已达成和解支付的相关款项","url":"https://stock-news.laohu8.com/highlight/detail?id=2642307622","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642307622?lang=zh_cn&edition=full","pubTime":"2026-06-12 08:02","pubTimestamp":1781222538,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物(06990)发布公告，有关本公司与苏州宜联生物医药有限公司(宜联生物医药)、薛彤彤博士、肖亮博士及蔡家强博士订立和解协议的相关事宜。根据已达成和解，本公司近日已收到宜联生物医药就YL201对外授权应分享给本公司的收入人民币6.025亿元。于2026年度及截至本公告日，本公司已收到宜联生物医药根据已达成和解支付的相关款项合计人民币7.027亿(包含前述人民币6.025亿元)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453467.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","LU0196878994.USD","BK4588","BK1161","BK4585","BK4581","XBI","06990","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642408310","title":"生物医药企业迈科康科创板IPO已问询 三年累计亏损11.41亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642408310","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642408310?lang=zh_cn&edition=full","pubTime":"2026-06-11 10:18","pubTimestamp":1781144284,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，6月10日，成都迈科康生物科技股份有限公司申请上交所科创板上市审核状态变更为“已问询”，中金公司为其保荐机构，拟募资29.29亿元。招股书显示，迈科康生物成立于2016年，是一家致力于创新疫苗和新型佐剂研发、生产和商业化的生物医药企业。核心产品针对老年人的重组呼吸道合胞病毒疫苗搭配了自主研发的MA103佐剂系统，该产品已进入III期临床试验阶段，有望成为首个获批上市的国产RSV疫苗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159982","161726","XBI","IPOS","399441","BK4585","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642459337","title":"新莱应材：产品目前主要应用于泛半导体、生物医药和食品安全等业务领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2642459337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642459337?lang=zh_cn&edition=full","pubTime":"2026-06-09 11:34","pubTimestamp":1780976066,"startTime":"0","endTime":"0","summary":"证券之星消息，新莱应材(300260)06月08日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司产品可用于商业航空航天火箭吗新莱应材回复：您好，公司主营业务为洁净应用材料和高纯及超高纯应用材料的研发、生产与销售，产品目前主要应用于泛半导体、生物医药和食品安全等业务领域，暂未应用于商业航空航天火箭相关领域。公司将持续关注相关行业的发展机遇，若有相关业务布局，公司将严格按照相关法律法规的要求及时履行信息披露义务。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900015137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0181","161726","159582","BK0159","BK0028","399441","300260","BK0259","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641486295","title":"中国宝安：公司控股及参股的企业涵盖高新技术、生物医药、房地产等产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2641486295","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641486295?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:02","pubTimestamp":1780912920,"startTime":"0","endTime":"0","summary":"证券日报网讯6月8日，中国宝安在互动平台回答投资者提问时表示，公司控股及参股的企业涵盖高新技术、生物医药、房地产等产业，详情可参见公司定期报告。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-08/doc-iniaswmn5476666.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-08/doc-iniaswmn5476666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399441","161726","BK0188","BK0265","09979","BK0037","BK4588","BK0139","XBI","000009","BK4585","BK1148","BK0131","BK0196","REET","BK0076","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783264180782,"stockEarnings":[{"period":"1week","weight":0.1207},{"period":"1month","weight":0.12},{"period":"3month","weight":-0.0405},{"period":"6month","weight":-0.0271},{"period":"1year","weight":-0.0174},{"period":"ytd","weight":-0.0271}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0421},{"period":"6month","weight":0.0188},{"period":"1year","weight":0.1683},{"period":"ytd","weight":0.0188}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物医药,399441,生物医药股票,生物医药股票老虎,生物医药股票老虎国际,生物医药行情,生物医药股票行情,生物医药股价,生物医药股市,生物医药股票价格,生物医药股票交易,生物医药股票购买,生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}